FDA approves blood test method for colon cancer screening

The FDA approved Guardant Health's Shield blood test for colon cancer screening, making it likely to be covered by Medicare and private insurers. It is effective at detecting later-stage cancers but not early-stage polyps. A positive result requires follow-up with a colonoscopy. Doctors see potential for increased screening rates, but its impact on reducing mortality remains to be seen.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3JMXuU1
via IFTTT

Comments

Popular posts from this blog

Minimum marriage age in England rises to 18 to crack down on forced marriage

Prince William resumes public duties after Princess Kate's cancer diagnosis